Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells
- 1 June 1984
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (12) , 1867-1872
- https://doi.org/10.1016/0006-2952(84)90541-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- 4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graftBritish Journal of Haematology, 1982
- Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamidesCancer Chemotherapy and Pharmacology, 1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Patterns of Resistance and Therapeutic Synergism among Alkylating Agents1Published by S. Karger AG ,1977
- Fractionation of DNA from mammalian cells by alkaline elutionBiochemistry, 1976
- Cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compoundsJournal of Medicinal Chemistry, 1975
- DNA chain growth during replication of asynchronous L1210 cells. Alkaline elution of large DNA segments from cells lysed on filtersBiochemistry, 1974
- 4-hydroxycyclophosphamide anhydro-dimer: revised structure of the fenton oxidation product of cyclophosphamideTetrahedron Letters, 1974
- A Dose-Response Study of Resistance of Leukemia L1210 to Cyclophosphamide2JNCI Journal of the National Cancer Institute, 1973
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968